Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (abre uma nova janela)

Brady KM, Easley RB, Tobias JD.

Fonte‎: Paediatr Anaesth 2006;16(10):1042-6.

Indexado‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (abre uma nova janela)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (abre uma nova janela)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Fonte‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

Indexado‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (abre uma nova janela)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (abre uma nova janela)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Fonte‎: Pediatrics 2002;110(1 Pt 1):169-71.

Indexado‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (abre uma nova janela)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (abre uma nova janela)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Fonte‎: Paediatr Drugs 2017;19(1):53-8.

Indexado‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (abre uma nova janela)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (abre uma nova janela)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Fonte‎: J Perinatol 2011;31(3):188-92.

Indexado‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (abre uma nova janela)

Use of recombinant factor VIIa in infants with severe coagulopathy. (abre uma nova janela)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Fonte‎: J Perinatol 2004;24(5):310-1.

Indexado‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (abre uma nova janela)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (abre uma nova janela)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Fonte‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

Indexado‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (abre uma nova janela)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (abre uma nova janela)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Fonte‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

Indexado‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (abre uma nova janela)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (abre uma nova janela)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Fonte‎: Paediatr Anaesth 2009;19(4):364-70.

Indexado‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (abre uma nova janela)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (abre uma nova janela)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Fonte‎: Spine 2004;29(12):1384-7.

Indexado‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (abre uma nova janela)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (abre uma nova janela)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Fonte‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

Indexado‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (abre uma nova janela)

Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (abre uma nova janela)

Olomu N, Kulkarni R, Manco-Johnson M.

Fonte‎: J Perinatol 2002;22(8):672-4.

Indexado‎: PubMed 12478454

DOI‎: 10.1038/sj.jp.7210787

https://www.ncbi.nlm.nih.gov/pubmed/12478454 (abre uma nova janela)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (abre uma nova janela)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Fonte‎: Pediatr Blood Cancer 2009;53(6):1074-8.

Indexado‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (abre uma nova janela)